| Document Date: 2011-04-13 04:15:02
Open Document File Size: 760,51 KBShare Result on Facebook
City Mannheim / Rico Cilag Europe / / Company Hospira / LG / Aventis / Amgen / Acs / Drug Names Binocrit Manufacturer Rentschler Biotechnologie GmbH / BIOCEUTICALS Arzneimittel AG / Unspecified Shanpoietin Shantha India / Epo / Biotec S.p.A. / Baxter / J&J / Affymax / HP / Norbitec GmbH / India Reliance GeneMedix Plc / / Continent Africa / Asia / Europe / / Country Mexico / Thailand / United States / Brazil / Canada / Argentina / Spain / India / / Facility Van Dyke / / IndustryTerm assistive devices / treatment for the signs and symptoms / medical imaging / post-translation processing / / MedicalCondition pre-dialysis chronic kidney disease / nausea / endstage renal disease / melanoma / fatigue / Chronic kidney disease / macrovascular disease / glomerulonephritis / renal disease / muscle cramps / end-stage renal disease / secondary hypertension / insomnia / uremia / hypertension / chronic dialysis / cystic kidney disease / tumors / disease / pre-dialysis kidney disease / diabetes-related renal disease / dyspnea / both glomerulonephritis / cancers/cancer / dysgeusia / classic microvascular renal disease / ESRD / chronic pathologic findings / diabetes / itching / bone sarcoma / hepatoblastoma / Anemia / disorders / / MedicalTreatment Dialysis / / NaturalFeature Erythropoietin-Unspecified Epotin Gulf / / Organization Medicare / FDA / European Union / / Person Kimberly Long / Elizabeth Koller / Day Handout / Coverage / Site - Continuous Erythropoietin Receptor Activator / Louis B. Jacques / James Rollins / / Position Deputy Director / Director / Medical Officer / Analyst / PhD Division Director / / Product Mircera / Aranesp / vitamin D / Eprex / / Region East Ireland / / Technology alpha / antibodies / transplantation / apoptosis / Dialysis / medical imaging / /
SocialTag |
Printed on[removed]Page 1 of 177 Proposed Decision Memo for Erythropoiesis Stimulating Agents (ESAs) for Treatment of Anemia in Adults with CKD Including Patients on Dialysis and Patients not on Dialysis (CAG-00413N